This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chen, W. Articles by Fine, H. A. Search for Related Content PubMed PubMed Citation Articles by Chen, W. Articles by Fine, H. A.

Proteasome-Mediated Destruction of the Cyclin A/Cyclin-Dependent Kinase 2 Complex Suppresses Tumor Cell Growth in Vitro and in Vivo

Neuro-Oncology Branch, National Cancer Institute, National Institutes of Neurological Disorder and Stroke, NIH, Bethesda, Maryland

Cyclin-dependent kinases (cdks) represent potentially promising molecular targets for cancer therapeutic strategies. To evaluate the antitumor activity of selective cyclin/cdk inhibition, we constructed a chimeric protein composed of a F-box protein (TrCP) fused to a peptide comprising the cyclin/cdk2 binding motif in p21-like cdk inhibitors (TrCP-LFG). We now demonstrate that endogenous cyclin A and its binding substrate, cdk2, can be tethered to ß-TrCP, ubiquitinated, and effectively degraded. Degradation of cdk2 and cyclin A together, but not cdk2 alone, results in massive tumor cell apoptosis in vitro and in vivo in a proteasome-dependent manner with no toxicity to normal tissue. These data demonstrate that cyclin A and/or the cyclin A/cdk2 complex is a promising anticancer target with a high therapeutic index.

This article has been cited by other articles:

				P. Ji, D. Sun, H. Wang, F. Bauzon, and L. Zhu Disrupting Skp2-cyclin A interaction with a blocking peptide induces selective cancer cell killing Mol. Cancer Ther., February 1, 2007; 6(2): 684 - 691. [Abstract] [Full Text] [PDF]

				D. Cai, V. M. Latham Jr., X. Zhang, and G. I. Shapiro Combined depletion of cell cycle and transcriptional cyclin-dependent kinase activities induces apoptosis in cancer cells. Cancer Res., September 15, 2006; 66(18): 9270 - 9280. [Abstract] [Full Text] [PDF]

				D. Cai, K. F. Byth, and G. I. Shapiro AZ703, an Imidazo[1,2-a]Pyridine Inhibitor of Cyclin-Dependent Kinases 1 and 2, Induces E2F-1-Dependent Apoptosis Enhanced by Depletion of Cyclin-Dependent Kinase 9 Cancer Res., January 1, 2006; 66(1): 435 - 444. [Abstract] [Full Text] [PDF]

				S. Y. Cho, L. Ravasi, L. P. Szajek, J. Seidel, M. V. Green, H. A. Fine, and W. C. Eckelman Evaluation of 76Br-FBAU as a PET Reporter Probe for HSV1-tk Gene Expression Imaging Using Mouse Models of Human Glioma J. Nucl. Med., November 1, 2005; 46(11): 1923 - 1930. [Abstract] [Full Text] [PDF]

				A. Wang, C. J. Li, P. V. Reddy, and A. B. Pardee Cancer Chemotherapy by Deoxynucleotide Depletion and E2F-1 Elevation Cancer Res., September 1, 2005; 65(17): 7809 - 7814. [Abstract] [Full Text] [PDF]

				S. Hatakeyama, M. Watanabe, Y. Fujii, and K. I. Nakayama Targeted Destruction of c-Myc by an Engineered Ubiquitin Ligase Suppresses Cell Transformation and Tumor Formation Cancer Res., September 1, 2005; 65(17): 7874 - 7879. [Abstract] [Full Text] [PDF]

				K. Schmidt, J. Hoffend, A. Altmann, L. G. Strauss, A. Dimitrakopoulou-Strauss, B. Engelhardt, D. Koczan, J. Peter, S. Vorwald, H. Eskerski, et al. Transfer of the sFLT-1 Gene in Morris Hepatoma Results in Decreased Growth and Perfusion and Induction of Genes Associated with Stress Response Clin. Cancer Res., March 15, 2005; 11(6): 2132 - 2140. [Abstract] [Full Text] [PDF]